Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

  1. Ortiz, S.
  2. Pittock, S.J.
  3. Berthele, A.
  4. Levy, M.
  5. Nakashima, I.
  6. Oreja-Guevara, C.
  7. Allen, K.
  8. Mashhoon, Y.
  9. Parks, B.
  10. Kim, H.J.
Aldizkaria:
Frontiers in Neurology

ISSN: 1664-2295

Argitalpen urtea: 2024

Alea: 15

Mota: Artikulua

DOI: 10.3389/FNEUR.2024.1332890 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus